Bottom line
EIFAX vs VPMCX: the short answer
EIFAX (Eaton Vance Floating-Rate Advantage Fund) and VPMCX (Vanguard PRIMECAP Fund) are both mutual funds.
But VPMCX is far broader, holding 173 positions to 1 for EIFAX, so beyond the top names it adds exposure EIFAX doesn't have.
VPMCX is cheaper at 0.35% vs 2.02% — a difference of $167 a year per $10,000 invested.
Over five years, VPMCX returned +14.3% a year vs +5.9% for EIFAX.
Updated Nov 19, 2026
EIFAX vs VPMCX side by side
| EIFAX | VPMCX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Morgan Stanley | Vanguard |
| Category | Large Blend | Large Blend |
| Expense ratio | 2.02% | 0.35% |
| Annual cost per $10k | $202 | $35 |
| 10-yr cost on $10k (prospectus) | $2,348 | $443 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +4.5% | +29.9% |
| 5-yr return (annualized) | +5.9% | +14.3% |
| 10-yr return (annualized) | +5.8% | +15.2% |
| Best quarter | — | +17.3% |
| Worst quarter | — | −20.2% |
| Net assets (fund) | $3.8B | $96.1B |
| Number of holdings | 1 | 173 |
| Portfolio turnover | 42% | 11% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
EIFAX and VPMCX share none of their top holdings.
EIFAX top 10
- Senior Debt Portfolio (MA) — 100.64%
VPMCX top 10
- Micron Technology Inc — 13.50%
- Intel Corp — 6.80%
- Eli Lilly & Co — 6.76%
- KLA Corp — 3.85%
- Alphabet Inc — 3.52%
- AstraZeneca PLC — 2.35%
- NVIDIA Corp — 2.33%
- Amazon.com Inc — 2.05%
- Tesla Inc — 1.89%
- Biogen Inc — 1.88%
FAQ
What is the difference between EIFAX and VPMCX?
EIFAX (Eaton Vance Floating-Rate Advantage Fund) and VPMCX (Vanguard PRIMECAP Fund) are both mutual funds. But VPMCX is far broader, holding 173 positions to 1 for EIFAX, so beyond the top names it adds exposure EIFAX doesn't have.
Which is cheaper, EIFAX or VPMCX?
VPMCX has the lower expense ratio (0.35%).
Should I own both EIFAX and VPMCX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.